The civil settlement was announced on a Tuesday morning in March, eight months after the night Edith Morrow died at Silver Pines. The news conference was held in the same federal courthouse where Judge Aldridge had denied Ravenwood's motion to dismiss, and the room was filled with the same reporters who had been covering the case since the beginning. But the atmosphere was different now. The fight was over, at least this part of it, and what remained was the accounting.
Isaac Voss stood at the podium, his heavy hands gripping the edges as if he were holding onto the side of a boat in rough seas. He wore a new suit, bought for the occasion, and his tie was straight for the first time since Hale had met him. Beside him stood Diana Ellison and Arthur Marcotte, and behind them, in the first row of the gallery, sat the families of the forty dead patients whose names had been published in the Register eight months earlier.
"The settlement provides for eight hundred million dollars in compensation to the class members," Voss read from a prepared statement. "The United Longshoremen pension fund and the other shareholders who were defrauded by Ravenwood's false statements will receive restitution. But more importantly, the settlement includes a consent decree requiring Ravenwood to implement independent safety monitoring for all clinical programs, to reform its adverse event reporting procedures, and to submit to external auditing for a period of ten years."
Hale sat in the back of the room, watching the proceedings with a feeling he could not quite name. It was not triumph. Triumph implied a battle won, an enemy vanquished, and while the settlement was a victory of sorts, it did not feel like an ending. It felt like a pause, a moment of stillness between one phase of the fight and the next.
The settlement did not include an admission of guilt. That was standard, the lawyers had explained. Settlements never included admissions of guilt. But it did include a statement of facts—a detailed recitation of what the company's internal documents had shown, what the witnesses had testified, what the evidence had proved. The statement of facts could not be used as an admission in the criminal trial, but it could be read by anyone who wanted to understand what had happened. And it was being read now, by reporters and regulators and the families of the dead.
The criminal trial of Marcus Draven and the six committee members was still months away. The settlement did not affect the criminal case, legally speaking, but everyone in the room knew that it would have an impact. The jurors would know that the company had paid eight hundred million dollars to make the civil case go away. The jurors would know that the company had agreed to a statement of facts that came as close to an admission as the law allowed. The machine's best defense—that the deaths were tragic accidents, that the company had done nothing wrong—had been rendered unsustainable.
After the news conference, Hale walked out of the courthouse and stood on the steps, watching the traffic move past on the street below. The March air was cold but no longer bitter, and the first buds were appearing on the trees that lined the courthouse plaza. Spring was coming, slow and tentative, the way it always came to Port Gantry.
Trina Vega appeared beside him. "You're not celebrating," she said.
"I'm thinking."
"About what?"
"About what happens next. The settlement is done. The criminal trial is still coming. But after that—what do I do? I'm not an investigator anymore. I'm not a night orderly anymore. I'm not sure what I am."
Trina lit a cigarette and blew smoke toward the pale sky. "You're the man who brought down a pharmaceutical company. That's not a bad thing to be."
"I didn't bring it down. The company is still standing. The executives are the ones who are falling."
"The company paid eight hundred million dollars and agreed to ten years of external monitoring. That's not nothing."
"It's not nothing. But it's not accountability, either. The people who designed the machine are going to prison, but the machine itself—the regulatory gaps, the legal loopholes, the assumptions that made it possible—those are still there. Other companies can build the same machine. Other companies probably already are."
Trina was quiet for a moment. "The FDOA hearing led to reform legislation. Congressman Thurmond introduced a bill last month that would close the Phase IV loophole and require independent adverse event verification. It has bipartisan support. It might actually pass."
"That's good. But legislation takes years. And the pharmaceutical industry has a lot of lobbyists."
"You're determined to be pessimistic today."
"I'm not pessimistic. I'm realistic." Hale turned to face her. "The night I found Edith Morrow, I thought I had discovered a crime. A specific crime, committed by specific people against specific victims. But what I actually discovered was a system. A system that was designed to produce exactly this outcome, and that would keep producing it until someone changed the rules."
"And you've helped change the rules. The hearing, the legislation, the consent decree—all of that happened because of what you started."
"I didn't start it. The people who died started it. I just noticed."
A car pulled up to the curb, and Ida Cross stepped out. She was wearing another new suit, her second in six months, and she had an energy about her that Hale had not seen before. The public defender who had taken his case when no one else would was becoming something else: a civil litigator with a growing reputation and a stack of job offers from firms that had once ignored her.
"There you are," she said. "I've been looking for you. Elaine Morse called. The criminal trial has been scheduled for September. She wants to meet with the witnesses next week to begin preparation."
"I'll be there."
"There's something else. Marlene Draper's cooperation agreement has been filed with the court. It's public now. She's agreed to testify against Draven and the committee members in exchange for immunity from prosecution. The agreement is... comprehensive."
"What does it say?"
"It says she was involved in the risk mitigation strategy from the beginning. She knew about the reclassification scheme. She helped design the consent forms. She was the one who identified you as a potential threat and developed the strategy to neutralize you." Ida paused. "But it also says she began cooperating with the government six months before Edith Morrow died. She was gathering evidence from the inside, building the case, waiting for the right moment to come forward. If what she says is true, she was working both sides for a very long time."
"She told me she was trying to stop the machine from the inside. I never knew whether to believe her."
"The agreement suggests she was telling the truth, at least partially. But it also suggests she was willing to let people die while she gathered evidence. The forty patients who died in the program—she could have stopped it earlier if she had come forward sooner."
Hale nodded. "That's what I keep coming back to. She had the evidence. She had the power to act. But she waited. She waited until the case was strong enough to win, and in the meantime, people kept dying."
"That's the calculation she made. The same calculation the company made, in a different form. Acceptable costs."
The three of them stood on the courthouse steps, the wind blowing cold from the harbor, the city spread out before them. Hale thought about the choices that Marlene Draper had made, the line she had walked between complicity and cooperation. She was not a hero, and she was not a villain. She was something in between, something that the law did not have a word for. She was a person who had done terrible things in the service of what she believed was a greater good, and the judgment of whether that was justified would depend on who was telling the story.
"What about the person above Draven?" Hale asked. "The one Marlene told me about on the phone. The one who approved the program and has been letting Draven take the fall."
Ida shook her head. "The discovery documents show that the final approval came from the executive committee, which included the CEO, the chairman of the board, and the head of the legal department. But none of them has been charged. The evidence against them is circumstantial. They can argue that Draven misled them, that they approved the program without knowing the details, that they were deceived by the clinical development team."
"So they walk away."
"They walk away from the criminal case. The civil settlement includes them in the class of released parties, which means they can't be sued individually. But they've been forced to resign. Harold Vance, Celia Drummond, Phillip Wessex—all of them have stepped down. Their careers in the pharmaceutical industry are over."
"That's not the same as accountability."
"No. It's not. But it's what the system can deliver." Ida looked at him. "Dominic, you've spent the past eight months fighting a machine that was designed to absorb people like you. You've been arrested, sued, threatened, and discredited. And despite all of that, you've forced one of the largest pharmaceutical companies in the country to pay eight hundred million dollars, reform its practices, and accept a statement of facts that will follow it for the rest of its existence. That's not nothing."
"It's not everything, either."
"No. But it's what we have."
That evening, Hale walked alone to the Port Gantry docks. The shipyard cranes were still, and the water was dark, and the wind carried the smell of salt and rust and the distant promise of spring. He stood at the edge of the pier and looked out at the harbor, at the lights of the fishing boats returning with the day's catch, at the gray horizon where the sea met the sky.
He thought about the forty names on Trina's list. He thought about Edith Morrow's frozen eyes and Walter Kemp's blood on the linoleum. He thought about the man in the suit who had asked them real questions about their pain and handed them papers they could not read. He thought about the machine that had been built around them, the regulatory gaps and legal loopholes and corporate calculations that had turned their deaths into an acceptable cost.
The machine was broken now, at least this version of it. The executives were going to prison, or had resigned in disgrace. The company had paid a price. The law had been stretched to accommodate a crime it was not designed to see.
But tomorrow, a different pharmaceutical company would design a different study that exploited a different gap. Tomorrow, a different regulatory agency would trust a different company to report its own adverse events. Tomorrow, the cycle would begin again, because the fundamental problem was not Ravenwood or Exaltrex or Marcus Draven. The fundamental problem was a system that trusted the powerful to regulate themselves, and then expressed surprise when they did not.
Hale pulled out his notebook, the new one that Trina had given him eight months ago, and opened it to a fresh page. He wrote:
Settlement: $800 million. Consent decree. No admission of guilt. Criminal trial: September. Marlene: cooperating. Executives: resigned. Machine: broken but not destroyed. The next machine is already being built.
He closed the notebook and put it back in his pocket. The wind was picking up, and the tide was coming in, and somewhere in the city behind him, the families of the dead were learning to live with what had happened. Somewhere, Margaret Driscoll was still alive in room fourteen at Silver Pines, her dose reduced, her window extended. Somewhere, Marlene Draper was waiting to testify, her gray eyes watching the final act of a drama she had helped to shape.
And somewhere, in the highest offices of a different pharmaceutical company, a different executive was reading about the Exaltrex case in the newspaper and thinking about how to avoid the same mistakes. Not how to avoid harming patients. How to avoid being caught.
Hale turned away from the water and began the long walk back to the city. He did not know what he would do next. The investigation was over. The settlement was complete. The criminal trial would proceed without him, its outcome now a matter for the lawyers and the jury.
But he had learned something in the past eight months, something he had not known when he was an investigator for the Social Insurance Board. He had learned that the most dangerous crimes were not the ones committed in secret. They were the ones committed in plain sight, hidden by the language of regulations and the assumptions of regulators. They were the crimes that did not look like crimes until someone pointed at them and said, Look.
He had pointed. Others had pointed with him. And for a moment, the machine had been visible.
The city lights were bright against the darkening sky, and the streets were filling with the evening crowds, ordinary people going about ordinary lives. Hale walked among them, a man who had won a battle in a war no one would ever finish. He was not a hero. He was not a crusader. He was just someone who had refused to look away.
And that, he thought, was enough.
No comments yet. Be the first to comment!